Načítá se...
Serum tumour marker CA 125 in monitoring of ovarian cancer during first-line chemotherapy
The value of the serum tumour marker CA 125 to date has been in the monitoring of ovarian cancer patients for response to therapy and for recurrence of disease. However, despite the availability of serial data on CA 125, the problem of interpreting a change over time is still unsolved. The aim of th...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Nature Publishing Group
2001
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2363637/ https://ncbi.nlm.nih.gov/pubmed/11355938 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1054/bjoc.2001.1787 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|